Erlanger Picked for National Study on Diagnosing Strokes


CHATTANOOGA, Tenn. (WDEF)- Numbers don’t lie—the Tri-state area records more strokes than anywhere else in the country!

That’s the reason for a unique clinical study now underway at Erlanger Medical Center.

- Advertisement -

The goal is early detection of traumatic brain injury from strokes, using the latest technology.

Dr. Thomas Devlin,who is the Chair of the Department of Neurology at Erlanger stated,  “The stroke is a major, major problem ..not only in the United States but throughout the world. The number one cause of disability in the united states. “

It’s also the number 2 cause of death in the world.

The Southeast Regional Stroke Center at Erlanger is working with a California company which has designed a portable diagnostic tool that could quickly provide life-saving information in the field.

Dr. Robert Hamilton who is with Neural Analytics said, “We plan on having three phases, of this specific trial, that’ll run through twenty-seventeen. And looking towards the beginning of twenty-eighteen, uh, for the results of those studies to be completed.”

Dr. Devlin said, “When an ambulance shows up, they would put this helmet-like technology over wouldn’t hurt them at all, There is no x-rays. No risk to the patient.”

For now, the study is done with a probe that is moved manually over the skull to find the blood clot that led to a stroke. The program is called  EXPEDITE.

“We just enrolled our first patient in a study last week. What this partnership will allow us to do is to come up with a unique technology that would be used in an ambulance, any pre-hospital could be used in an airplane …It could be used at a football field …it could be used where ever.”

Previous studies indicate people benefit from very early and very invasive procedures.

Dr. Charles Campbell, who is the Chief of Cardiovascular Medicine said,  “And you have to identify those patients who will benefit as soon as possible so their care is not delayed and they are not transferred to hospitals where they do not offer this sort of therapy.”

When medical personnel know exactly where the clot is, they can manually pull it out.

The study will eventually involve 150 patients who are suspected of having a Large Vessel Occlusion Stroke.

Erlanger doctors want to know if the Neural Analytics’ technology can help in quickly assessing the location of the blockage.